AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, ...
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
Ken Hall takes a look at two big-name retirement shares in the FTSE 100 with market-leading positions and track records of ...